about
The evolution of genome-scale models of cancer metabolismDevelopment and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapyMutational profiling of kinases in glioblastoma.A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemiaA proteome-scale map of the human interactome networkCancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspiratesSomatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesGenetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer MedicineThe Cancer Genome Atlas Pan-Cancer analysis projectCancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsFirst-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancerOptimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccinesNeoantigen-based cancer immunotherapyMolecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingCell Fusion in the War on Cancer: A Perspective on the Inception of MalignancyProtein oxidation, UVA and human DNA repairInflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatmentThe cilia-regulated proteasome and its role in the development of ciliopathies and cancerEvaluating biomarkers to model cancer risk post cosmic ray exposureSomatic mutations in disorders with disrupted brain connectivityThe value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersThe Obesity-Breast Cancer Conundrum: An Analysis of the IssuesPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaCell-free circulating tumor DNA in cancerGenomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersGenetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapyThe dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionLearning about the Importance of Mutation Prevention from Curable Cancers and Benign TumorsUnderstanding Genotype-Phenotype Effects in Cancer via Network ApproachesCurrent therapeutic strategies for advanced pancreatic cancer: A review for cliniciansGenomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencingNovel technologies and emerging biomarkers for personalized cancer immunotherapyMethylated circulating tumor DNA in blood: power in cancer prognosis and responseGATA3 in Breast Cancer: Tumor Suppressor or Oncogene?Leaving the lysosome behind: novel developments in autophagy inhibitionIntegration of genome scale data for identifying new players in colorectal cancerCirculating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer
P2860
Q21129241-6E3F9DB3-D38F-4DB6-AF7A-41624F82D0BEQ21131727-78C0264C-E475-41C7-9B77-C0E82C7A695AQ21261249-FCB2EDCB-147F-4736-8C05-2C513B79973EQ24289222-B105D1B6-A4D2-4843-B44C-02F7AA951D8FQ24307146-FBA520F6-9EE9-4DCE-892B-D9F74A1D8198Q24564079-F5DA1A41-EEE4-445C-8232-3EFD87242A15Q24568313-9E7E416D-2D1B-42A2-A4E1-810318938299Q24596715-63E1D681-14D4-427D-BBB4-CF460437C092Q24604479-5227EEE7-FDDE-4EC0-A51B-60436B379B27Q24606808-8B8FA2E8-CDD5-4E95-9662-093D337AE2E7Q26261171-0185C5E1-CBFA-43EC-A847-D1D067BB966CQ26471909-CB96C33C-C068-4287-BC89-B45F63229A42Q26738680-5BBB71E5-B84A-4CD2-950C-D4A6489CF8D3Q26738693-F98AC4D3-60BD-4A2B-AFE0-3EF057427687Q26739662-815A546D-3145-4587-B2C4-DC6F310F7CBAQ26740111-E0CD10BA-D1C5-4C94-88C3-18EB3B789526Q26744266-060992B7-AD4C-417C-91E4-1C72DA4D0094Q26745456-01FFA816-5FA2-4826-9043-B4FE390B4274Q26746930-92BD21DC-AC70-4D3B-8F17-317312C055B7Q26747120-710AFC1F-8FEB-4823-B25E-9AAB879ED75BQ26747309-055C836C-32AB-443F-98A8-814E7D630AC1Q26747403-1016183A-50BF-4908-BC3D-502D7945CB69Q26747486-9F748853-0BB5-45A1-805F-DB391F35C8BEQ26748603-D51661F4-2FCF-46EB-9FFD-F71E6E38F719Q26750641-14D3D1F8-9593-4477-94B7-C759FA210DC5Q26750899-19A1F2D3-001C-4411-B219-2A74A9D4F0CEQ26751068-18E2844C-3582-43D6-A8F3-456AE4C09FB8Q26751655-169DFA81-B059-47B3-B27C-FD2D441AA764Q26753387-D1BFC073-0CA6-4CBB-9AD4-A47B20579BA2Q26766149-16D52C73-F579-48EF-86DE-C5361DF571D3Q26766238-30F34E9B-EE9F-40FC-8549-43C139C1212CQ26766543-E2A1102A-EE3E-4BF6-B937-4619AF628457Q26767041-BC5440CB-CA28-48E1-BCC5-2F8351876CC8Q26768533-4E97AAA4-853C-427A-8CC6-BE421C9B767CQ26770780-3FEF2FF1-9030-4FCB-89B7-5DF9B14C7B05Q26772077-0A248147-53C0-4AC3-8DB9-01DAA4EC8E38Q26774304-45B7A7CD-98C7-41CD-9A33-0B94B941DFC0Q26774549-4CC4CD68-CED5-4C36-9B34-374C8BB201BAQ26774701-90C675A0-B335-4470-890A-991B965E790DQ26775376-2A5DB1AC-4753-4655-835D-FDF063D45371
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cancer genome landscapes
@ast
Cancer genome landscapes
@en
Cancer genome landscapes
@en-gb
Cancer genome landscapes
@nl
type
label
Cancer genome landscapes
@ast
Cancer genome landscapes
@en
Cancer genome landscapes
@en-gb
Cancer genome landscapes
@nl
prefLabel
Cancer genome landscapes
@ast
Cancer genome landscapes
@en
Cancer genome landscapes
@en-gb
Cancer genome landscapes
@nl
P2860
P50
P3181
P356
P1433
P1476
Cancer genome landscapes
@en
P2093
Nickolas Papadopoulos
Shibin Zhou
P2860
P304
P3181
P356
10.1126/SCIENCE.1235122
P407
P5008
P577
2013-03-29T00:00:00Z